Aug. 14 at 3:41 PM
$ELTP $GME $WEN $DJT
Roaring Kitty is on the call, I heard a meow in the background !!
(ELTP) is generating positive momentum, largely driven by its innovative product SequestOx™, which is currently FDA pending. SequestOx is an investigational immediate-release oxycodone combined with sequestered naltrexone, designed as an abuse-deterrent opioid product. This novel formulation aims to address the critical issue of opioid abuse while providing effective pain management.
The FDA approval of SequestOx will be a significant milestone, positioning it as a potential game changer in the pharmaceutical market. Its unique abuse-deterrent properties could set a new standard for opioid medications, offering both safety and efficacy.
I SequestOx is a promising advancement in opioid therapy, and its pending FDA status adds substantial value to Elite Pharmaceuticals. If approved, SequestOx will revolutionize pain management and abuse prevention.
We Will Run Past .40 after the good news.